Breaking News Instant updates and real-time market news.

BABA

Alibaba

$173.57

4.39 (2.59%)

07:22
10/22/19
10/22
07:22
10/22/19
07:22

Daiwa expects 'solid' results from Alibaba, keeps $235 price target

Daiwa analyst John Choi expects Alibaba to report "solid" fiscal Q2 results on November 1. The analyst, while expecting largely inline revenue, looks for a positive surprise in Alibaba's core commerce EBITA, underpinned by strengthening customer management revenue growth and "rational spending" in Ele.me. Choi keeps a Buy rating on Alibaba shares with a $235 price target.

  • 01

    Nov

  • 19

    Nov

BABA Alibaba
$173.57

4.39 (2.59%)

09/10/19
BOFA
09/10/19
NO CHANGE
Target $39
BOFA
Buy
Easing competition presents potential upside for Pinduoduo, says BofA/Merrill
BofA Merrill Lynch analyst Joyce Ju said her proprietary price point checks on some products across Chinese e-commerce platforms, including Alibaba's (BABA) Taobao, support the assumption of a stabilized competitive landscape and less aggressive promotion in Q3. The easing price competition should give Pinduoduo (PDD) more budget flexibility and room for moderate margin upside in non-peak season, according to Ju, who raised her price target on the stock to $39 from $34. She maintains a Buy rating on Pinduoduo.
09/16/19
SBSH
09/16/19
NO CHANGE
Target $233
SBSH
Buy
Alibaba unlikely to revise sales guidance at investor day, says Citi
Citi analyst Alicia Yap expects Alibaba's September 23 and 24 investor days to focus on new chairman and CEO Daniel Zhang's vision and strategy, the CFO's comments on investment strategy and margins, and progress and customer feedback on recommended feeds and Tmall 2.0 initiatives. The analyst believes the CFO is unlikely to revise Alibaba's fiscal 2020 revenue guidance, and instead will likely offer reassurance on "healthy" growth in core marketplace margins and on a disciplined approach to new investment initiatives. Yap keeps a Buy rating on Alibaba shares with a $233 price target.
10/04/19
HSBC
10/04/19
NO CHANGE
Target $233
HSBC
Buy
HSBC boosts Alibaba target to $233 on continued dominance in retail market
After hosting a dinner with an apparel brand expert, HSBC analyst Binnie Wong says Alibaba (BABA) "remains dominant." Alibaba is still leading the way in the brands' online retail market, Wong tells investors in a research note. Further, Tmall is more effective in new products launches, with higher profits for Alibaba versus Pinduoduo (PDD), contends the analyst. Wong views Alibaba as attractively valued and boosted the stock's price target to $233 from $230. The analyst keeps a Buy rating on the shares.
10/21/19
STFL
10/21/19
NO CHANGE
Target $35
STFL
Buy
Stifel adds Peloton to Select List, removes Alibaba
Stifel added Peloton Interactive (PTON), a stock analyst Scott Devitt initiated this morning with a Buy rating and $35 price target, to its Select List. The firm also removed Alibaba Group Holding (BABA) from the Stifel Select List.

TODAY'S FREE FLY STORIES

CELG

Celgene

$110.03

-0.42 (-0.38%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Hot Stocks
Celgene receives positive CHMP opinion for REVLIMID »

Celgene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Hot Stocks
J.C. Penney CEO says 'made significant progress' on efforts to return to growth »

"The past quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BABA

Alibaba

$182.69

0.21 (0.12%)

, STAY

Extended Stay America

$14.69

0.12 (0.82%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BABA

Alibaba

$182.69

0.21 (0.12%)

STAY

Extended Stay America

$14.69

0.12 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

07:35
11/15/19
11/15
07:35
11/15/19
07:35
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:33
11/15/19
11/15
07:33
11/15/19
07:33
Hot Stocks
J.C. Penney expects FY19 adjusted EBITDA to exceed $475M »

In addition, the Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

RIGL

Rigel Pharmaceuticals

$2.29

-0.065 (-2.77%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Hot Stocks
Rigel Pharmaceuticals receives positive CHMP opinion for fostamatinib »

Rigel Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Hot Stocks
J.C. Penney reports Q3 SSS down 9.3% »

Adjusted comparable store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CGC

Canopy Growth

$15.84

-2.68 (-14.47%)

07:32
11/15/19
11/15
07:32
11/15/19
07:32
Recommendations
Canopy Growth analyst commentary  »

Canopy Growth price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

JCP

J.C. Penney

$1.10

0.01 (0.92%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Earnings
J.C. Penney reports Q3 adjusted EPS (30c), consensus (55c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ADS

Alliance Data

$106.55

-0.57 (-0.53%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Hot Stocks
Alliance Data reports October net charge offs 6.6% vs. 5.3% last month »

Reports October…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$56.89

-0.24 (-0.42%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

TORC

resTORbio

$7.93

-0.47 (-5.60%)

07:31
11/15/19
11/15
07:31
11/15/19
07:31
Hot Stocks
Breaking Hot Stocks news story on resTORbio 

resTORbio trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$7.49

-0.54 (-6.72%)

07:30
11/15/19
11/15
07:30
11/15/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$120.65

-0.41 (-0.34%)

07:28
11/15/19
11/15
07:28
11/15/19
07:28
Recommendations
Walmart analyst commentary  »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$7.49

-0.54 (-6.72%)

07:26
11/15/19
11/15
07:26
11/15/19
07:26
Recommendations
Farfetch analyst commentary  »

Farfetch price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

(0.00%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin shares up 21c to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

GLPG

Galapagos

$183.48

-7.74 (-4.05%)

, GILD

Gilead

$63.79

0.46 (0.73%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Recommendations
Galapagos, Gilead analyst commentary  »

Galapagos price target…

GLPG

Galapagos

$183.48

-7.74 (-4.05%)

GILD

Gilead

$63.79

0.46 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 21

    Feb

VAR

Varian Medical

$125.01

0.45 (0.36%)

07:25
11/15/19
11/15
07:25
11/15/19
07:25
Conference/Events
Varian Medical to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

OCUL

Ocular Therapeutix

$2.67

-0.1 (-3.61%)

07:23
11/15/19
11/15
07:23
11/15/19
07:23
Recommendations
Ocular Therapeutix analyst commentary  »

Ocular Therapeutix price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$26.68

-1.42 (-5.05%)

07:23
11/15/19
11/15
07:23
11/15/19
07:23
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBLX

Noble Midstream

$22.29

-0.36 (-1.59%)

07:22
11/15/19
11/15
07:22
11/15/19
07:22
Recommendations
Noble Midstream analyst commentary  »

Noble Midstream price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$21.43

-0.08 (-0.37%)

07:22
11/15/19
11/15
07:22
11/15/19
07:22
Conference/Events
Associated Banc-Corpmanagement to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 18

    Nov

NVDA

Nvidia

$209.88

1.33 (0.64%)

07:21
11/15/19
11/15
07:21
11/15/19
07:21
Upgrade
Nvidia rating change  »

Nvidia upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 06

    Jan

NCNA

NuCana

$5.59

-0.35 (-5.89%)

07:21
11/15/19
11/15
07:21
11/15/19
07:21
Recommendations
NuCana analyst commentary  »

NuCana price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

(0.00%)

07:19
11/15/19
11/15
07:19
11/15/19
07:19
Recommendations
Amarin shares could move towards $51 after positive vote, says H.C. Wainwright »

Following the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.